-
In this issue: Apixaban could soon join the anticoagulation market; Chinese herbs for flu; chronic medication and discontinuation after hospitalization; and FDA actions.
-
Bacterial meningitis is a feared medical illness that has a high morbidity and mortality rate. Meningitis can present in any age group, although the predominant pathogenic organisms do vary by age.
-
Physicians at the University of California-San Diego (UCSD) report a cluster of 5 cases of cutaneous Leishmaniasis in illegal immigrants from East Africa, which surprisingly turned out to be consistent with New World Leishmaniasis, although all 5 had come from an area endemic for Old World Leishmaniasis. How did this occur?
-
In most communities in the united states, hepatitis c (HepC) treatment is provided by gastroenterologists.
-
In this issue: ACEI/ARB therapy for AS; safety alert issued for dronedarone; statins and cancer risk; nesiritide and heart failure; and FDA actions.
-
Add TDAP to the growing list of recommended (and often required) vaccinations for health care workers (HCWs) in hospital, including MMR, hepatitis B, influenza, and possibly varicella.
-
-
-
Adding gabapentin to valacyclovir early in the treatment of acute herpes zoster may reduce the incidence of postherpetic neuralgia.
-
The FDA has approved a second three-drug fixed combination for the treatment of HIV-1 infections. This combination contains two nucleoside analog HIV-1 reverse transcriptase inhibitors (emtricitabine and tenofovir) and a non-nucleoside reverse transcriptase inhibitor (NNRTI; rilpivirine).